List of Tables
Table 1. Targeted Oncology Drugs Market Trends
Table 2. Targeted Oncology Drugs Market Drivers & Opportunity
Table 3. Targeted Oncology Drugs Market Challenges
Table 4. Targeted Oncology Drugs Market Restraints
Table 5. Global Targeted Oncology Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Targeted Oncology Drugs Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Targeted Oncology Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Targeted Oncology Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Targeted Oncology Drugs
Table 10. Global Targeted Oncology Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Oncology Drugs as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Targeted Oncology Drugs Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Targeted Oncology Drugs Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Targeted Oncology Drugs Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Targeted Oncology Drugs Sales Market Share in Value by Type (2020-2025)
Table 17. Global Targeted Oncology Drugs Sales Market Share in Value by Type (2026-2031)
Table 18. Global Targeted Oncology Drugs Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Targeted Oncology Drugs Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Targeted Oncology Drugs Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Targeted Oncology Drugs Sales Market Share in Value by Application (2020-2025)
Table 22. Global Targeted Oncology Drugs Sales Market Share in Value by Application (2026-2031)
Table 23. Global Targeted Oncology Drugs Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Targeted Oncology Drugs Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Targeted Oncology Drugs Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Targeted Oncology Drugs Sales Value by Region (2020-2025) & (%)
Table 27. Global Targeted Oncology Drugs Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Targeted Oncology Drugs Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Targeted Oncology Drugs Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Targeted Oncology Drugs Sales Value, (2026-2031) & (US$ Million)
Table 31. AbbVie Basic Information List
Table 32. AbbVie Description and Business Overview
Table 33. AbbVie Targeted Oncology Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Targeted Oncology Drugs Business of AbbVie (2020-2025)
Table 35. AbbVie Recent Developments
Table 36. Johnson & Johnson Basic Information List
Table 37. Johnson & Johnson Description and Business Overview
Table 38. Johnson & Johnson Targeted Oncology Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Targeted Oncology Drugs Business of Johnson & Johnson (2020-2025)
Table 40. Johnson & Johnson Recent Developments
Table 41. Novartis Basic Information List
Table 42. Novartis Description and Business Overview
Table 43. Novartis Targeted Oncology Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Targeted Oncology Drugs Business of Novartis (2020-2025)
Table 45. Novartis Recent Developments
Table 46. Gilead Sciences Basic Information List
Table 47. Gilead Sciences Description and Business Overview
Table 48. Gilead Sciences Targeted Oncology Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Targeted Oncology Drugs Business of Gilead Sciences (2020-2025)
Table 50. Gilead Sciences Recent Developments
Table 51. Roche Basic Information List
Table 52. Roche Description and Business Overview
Table 53. Roche Targeted Oncology Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Targeted Oncology Drugs Business of Roche (2020-2025)
Table 55. Roche Recent Developments
Table 56. Bristol-Myers Squibb Basic Information List
Table 57. Bristol-Myers Squibb Description and Business Overview
Table 58. Bristol-Myers Squibb Targeted Oncology Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Targeted Oncology Drugs Business of Bristol-Myers Squibb (2020-2025)
Table 60. Bristol-Myers Squibb Recent Developments
Table 61. Amgen Basic Information List
Table 62. Amgen Description and Business Overview
Table 63. Amgen Targeted Oncology Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Targeted Oncology Drugs Business of Amgen (2020-2025)
Table 65. Amgen Recent Developments
Table 66. AstraZeneca Basic Information List
Table 67. AstraZeneca Description and Business Overview
Table 68. AstraZeneca Targeted Oncology Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Targeted Oncology Drugs Business of AstraZeneca (2020-2025)
Table 70. AstraZeneca Recent Developments
Table 71. Merck & Co Basic Information List
Table 72. Merck & Co Description and Business Overview
Table 73. Merck & Co Targeted Oncology Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Targeted Oncology Drugs Business of Merck & Co (2020-2025)
Table 75. Merck & Co Recent Developments
Table 76. Takeda Basic Information List
Table 77. Takeda Description and Business Overview
Table 78. Takeda Targeted Oncology Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Targeted Oncology Drugs Business of Takeda (2020-2025)
Table 80. Takeda Recent Developments
Table 81. Merck KGaA Basic Information List
Table 82. Merck KGaA Description and Business Overview
Table 83. Merck KGaA Targeted Oncology Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Targeted Oncology Drugs Business of Merck KGaA (2020-2025)
Table 85. Merck KGaA Recent Developments
Table 86. Seagen Basic Information List
Table 87. Seagen Description and Business Overview
Table 88. Seagen Targeted Oncology Drugs Products, Services and Solutions
Table 89. Revenue (US$ Million) in Targeted Oncology Drugs Business of Seagen (2020-2025)
Table 90. Seagen Recent Developments
Table 91. Eli Lilly Basic Information List
Table 92. Eli Lilly Description and Business Overview
Table 93. Eli Lilly Targeted Oncology Drugs Products, Services and Solutions
Table 94. Revenue (US$ Million) in Targeted Oncology Drugs Business of Eli Lilly (2020-2025)
Table 95. Eli Lilly Recent Developments
Table 96. Ono Pharmaceutical Basic Information List
Table 97. Ono Pharmaceutical Description and Business Overview
Table 98. Ono Pharmaceutical Targeted Oncology Drugs Products, Services and Solutions
Table 99. Revenue (US$ Million) in Targeted Oncology Drugs Business of Ono Pharmaceutical (2020-2025)
Table 100. Ono Pharmaceutical Recent Developments
Table 101. Pfizer Basic Information List
Table 102. Pfizer Description and Business Overview
Table 103. Pfizer Targeted Oncology Drugs Products, Services and Solutions
Table 104. Revenue (US$ Million) in Targeted Oncology Drugs Business of Pfizer (2020-2025)
Table 105. Pfizer Recent Developments
Table 106. GSK Basic Information List
Table 107. GSK Description and Business Overview
Table 108. GSK Targeted Oncology Drugs Products, Services and Solutions
Table 109. Revenue (US$ Million) in Targeted Oncology Drugs Business of GSK (2020-2025)
Table 110. GSK Recent Developments
Table 111. Exelixis Basic Information List
Table 112. Exelixis Description and Business Overview
Table 113. Exelixis Targeted Oncology Drugs Products, Services and Solutions
Table 114. Revenue (US$ Million) in Targeted Oncology Drugs Business of Exelixis (2020-2025)
Table 115. Exelixis Recent Developments
Table 116. Regeneron Basic Information List
Table 117. Regeneron Description and Business Overview
Table 118. Regeneron Targeted Oncology Drugs Products, Services and Solutions
Table 119. Revenue (US$ Million) in Targeted Oncology Drugs Business of Regeneron (2020-2025)
Table 120. Regeneron Recent Developments
Table 121. Innovent Basic Information List
Table 122. Innovent Description and Business Overview
Table 123. Innovent Targeted Oncology Drugs Products, Services and Solutions
Table 124. Revenue (US$ Million) in Targeted Oncology Drugs Business of Innovent (2020-2025)
Table 125. Innovent Recent Developments
Table 126. Hengrui Medicine Basic Information List
Table 127. Hengrui Medicine Description and Business Overview
Table 128. Hengrui Medicine Targeted Oncology Drugs Products, Services and Solutions
Table 129. Revenue (US$ Million) in Targeted Oncology Drugs Business of Hengrui Medicine (2020-2025)
Table 130. Hengrui Medicine Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Targeted Oncology Drugs Downstream Customers
Table 134. Targeted Oncology Drugs Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Targeted Oncology Drugs Product Picture
Figure 2. Global Targeted Oncology Drugs Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Targeted Oncology Drugs Sales Value (2020-2031) & (US$ Million)
Figure 4. Targeted Oncology Drugs Report Years Considered
Figure 5. Global Targeted Oncology Drugs Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Targeted Oncology Drugs Revenue in 2024
Figure 7. Targeted Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Kinase Inhibitors Picture
Figure 9. Monoclonal Antibodies Picture
Figure 10. PARP Inhibitors Picture
Figure 11. Other Picture
Figure 12. Global Targeted Oncology Drugs Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 13. Global Targeted Oncology Drugs Sales Value Market Share by Type, 2024 & 2031
Figure 14. Product Picture of Lung Cancer
Figure 15. Product Picture of Breast Cancer
Figure 16. Product Picture of Prostate Cancer
Figure 17. Product Picture of Blood-related Cancer
Figure 18. Product Picture of Other
Figure 19. Global Targeted Oncology Drugs Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 20. Global Targeted Oncology Drugs Sales Value Market Share by Application, 2024 & 2031
Figure 21. North America Targeted Oncology Drugs Sales Value (2020-2031) & (US$ Million)
Figure 22. North America Targeted Oncology Drugs Sales Value by Country (%), 2024 VS 2031
Figure 23. Europe Targeted Oncology Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 24. Europe Targeted Oncology Drugs Sales Value by Country (%), 2024 VS 2031
Figure 25. Asia Pacific Targeted Oncology Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 26. Asia Pacific Targeted Oncology Drugs Sales Value by Region (%), 2024 VS 2031
Figure 27. South America Targeted Oncology Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 28. South America Targeted Oncology Drugs Sales Value by Country (%), 2024 VS 2031
Figure 29. Middle East & Africa Targeted Oncology Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 30. Middle East & Africa Targeted Oncology Drugs Sales Value by Country (%), 2024 VS 2031
Figure 31. Key Countries/Regions Targeted Oncology Drugs Sales Value (%), (2020-2031)
Figure 32. United States Targeted Oncology Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 33. United States Targeted Oncology Drugs Sales Value by Type (%), 2024 VS 2031
Figure 34. United States Targeted Oncology Drugs Sales Value by Application (%), 2024 VS 2031
Figure 35. Europe Targeted Oncology Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 36. Europe Targeted Oncology Drugs Sales Value by Type (%), 2024 VS 2031
Figure 37. Europe Targeted Oncology Drugs Sales Value by Application (%), 2024 VS 2031
Figure 38. China Targeted Oncology Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 39. China Targeted Oncology Drugs Sales Value by Type (%), 2024 VS 2031
Figure 40. China Targeted Oncology Drugs Sales Value by Application (%), 2024 VS 2031
Figure 41. Japan Targeted Oncology Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 42. Japan Targeted Oncology Drugs Sales Value by Type (%), 2024 VS 2031
Figure 43. Japan Targeted Oncology Drugs Sales Value by Application (%), 2024 VS 2031
Figure 44. South Korea Targeted Oncology Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 45. South Korea Targeted Oncology Drugs Sales Value by Type (%), 2024 VS 2031
Figure 46. South Korea Targeted Oncology Drugs Sales Value by Application (%), 2024 VS 2031
Figure 47. Southeast Asia Targeted Oncology Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 48. Southeast Asia Targeted Oncology Drugs Sales Value by Type (%), 2024 VS 2031
Figure 49. Southeast Asia Targeted Oncology Drugs Sales Value by Application (%), 2024 VS 2031
Figure 50. India Targeted Oncology Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 51. India Targeted Oncology Drugs Sales Value by Type (%), 2024 VS 2031
Figure 52. India Targeted Oncology Drugs Sales Value by Application (%), 2024 VS 2031
Figure 53. Targeted Oncology Drugs Industrial Chain
Figure 54. Targeted Oncology Drugs Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
